You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Details for Patent: 8,778,999

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,778,999 protect, and when does it expire?

Patent 8,778,999 protects BROMSITE and is included in one NDA.

This patent has six patent family members in six countries.

Summary for Patent: 8,778,999

Title:	Non-steroidal anti-inflammatory ophthalmic compositions
Abstract:	The disclosure provides compositions and systems for topical ophthalmic application, which include an aqueous mixture of bromfenac and flowable mucoadhesive polymer, for treating inflammation and inflammatory conditions of the eye.
Inventor(s):	Hosseini; Kamran (Los Altos, CA), Bowman; Lyle (Pleasanton, CA), Si; Erwin C. (Alameda, CA), Pham; Stephen (Sacramento, CA)
Assignee:	Insite Vision Incorporated (Alameda, CA)
Application Number:	12/398,657
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,778,999
Patent Claim Types: see list of patent claims	Composition; Use;

Drugs Protected by US Patent 8,778,999

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sun Pharm	BROMSITE	bromfenac sodium	SOLUTION/DROPS;OPHTHALMIC	206911-001	Apr 8, 2016	AB	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			TREATMENT OF POSTOPERATIVE INFLAMMATION AND PREVENTION OF OCULAR PAIN IN PATIENTS UNDERGOING CATARACT SURGERY	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,778,999

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2753947	⤷ Try a Trial
Denmark	2403493	⤷ Try a Trial
European Patent Office	2403493	⤷ Try a Trial
Spain	2586064	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.